95 related articles for article (PubMed ID: 9143246)
1. An antisense oligodeoxynucleotide complementary to corticotropin-releasing hormone mRNA inhibits rat splenocyte proliferation in vitro.
Jessop DS; Harbuz MS; Snelson CL; Dayan CM; Lightman SL
J Neuroimmunol; 1997 May; 75(1-2):135-40. PubMed ID: 9143246
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats.
Skutella T; Montkowski A; Stöhr T; Probst JC; Landgraf R; Holsboer F; Jirikowski GF
Cell Mol Neurobiol; 1994 Oct; 14(5):579-88. PubMed ID: 7621515
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat.
Skutella T; Criswell H; Moy S; Probst JC; Breese GR; Jirikowski GF; Holsboer F
Neuroreport; 1994 Oct; 5(16):2181-5. PubMed ID: 7865772
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligodeoxynucleotides for in vivo targeting of corticotropin-releasing hormone mRNA: comparison of phosphorothioate and 3'-inverted probe performance.
Skutella T; Stöhr T; Probst JC; Ramalho-Ortigao FJ; Holsboer F; Jirikowski GF
Horm Metab Res; 1994 Oct; 26(10):460-4. PubMed ID: 7851868
[TBL] [Abstract][Full Text] [Related]
5. Long-term intracerebroventricular corticotropin-releasing hormone administration induces distinct changes in rat splenocyte activation and cytokine expression.
Labeur MS; Arzt E; Wiegers GJ; Holsboer F; Reul JM
Endocrinology; 1995 Jun; 136(6):2678-88. PubMed ID: 7750492
[TBL] [Abstract][Full Text] [Related]
6. Antisense inhibition of pro-opiomelanocortin and proenkephalin A messenger RNA translation alters rat immune cell function in vitro.
Fulford AJ; Harbuz MS; Jessop DS
J Neuroimmunol; 2000 Jul; 106(1-2):6-13. PubMed ID: 10814777
[TBL] [Abstract][Full Text] [Related]
7. A corticotropin-releasing hormone antisense oligodeoxynucleotide reduces spontaneous waking in the rat.
Chang FC; Opp MR
Regul Pept; 2004 Jan; 117(1):43-52. PubMed ID: 14687700
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligodeoxynucleotide complementary to platelet-derived growth factor A-chain messenger RNA inhibits the arterial proliferation in spontaneously hypertensive rats without altering their blood pressures.
Fukuda N; Kubo A; Watanabe Y; Nakayama T; Soma M; Izumi Y; Kanmatsuse K
J Hypertens; 1997 Oct; 15(10):1123-36. PubMed ID: 9350586
[TBL] [Abstract][Full Text] [Related]
9. An antisense oligodeoxynucleotide to growth hormone messenger ribonucleic acid inhibits lymphocyte proliferation.
Weigent DA; Blalock JE; LeBoeuf RD
Endocrinology; 1991 Apr; 128(4):2053-7. PubMed ID: 2004616
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing hormone deficiency results in impaired splenocyte response to lipopolysaccharide.
Venihaki M; Zhao J; Karalis KP
J Neuroimmunol; 2003 Aug; 141(1-2):3-9. PubMed ID: 12965248
[TBL] [Abstract][Full Text] [Related]
11. Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain.
Liebsch G; Landgraf R; Engelmann M; Lörscher P; Holsboer F
J Psychiatr Res; 1999; 33(2):153-63. PubMed ID: 10221747
[TBL] [Abstract][Full Text] [Related]
12. Local production of corticotropin releasing hormone is increased in experimental intestinal inflammation in rats.
van Tol EA; Petrusz P; Lund PK; Yamauchi M; Sartor RB
Gut; 1996 Sep; 39(3):385-92. PubMed ID: 8949642
[TBL] [Abstract][Full Text] [Related]
13. The corticotropin releasing hormone gene is expressed in human placenta.
Grino M; Chrousos GP; Margioris AN
Biochem Biophys Res Commun; 1987 Nov; 148(3):1208-14. PubMed ID: 3318828
[TBL] [Abstract][Full Text] [Related]
14. Evidence that CRH microinfused into the locus coeruleus decreases cell-mediated immune response in rats.
Caroleo MC; Pulvirenti L; Arbitrio M; Lopilato R; Nisticò G
Funct Neurol; 1993; 8(4):271-7. PubMed ID: 8314119
[TBL] [Abstract][Full Text] [Related]
15. Lamotrigine inhibits basal and Na+-stimulated, but not Ca2+-stimulated, release of corticotropin-releasing hormone from the rat hypothalamus.
Tringali G; Aubry JM; Navarra P; Pozzoli G
Psychopharmacology (Berl); 2006 Oct; 188(3):386-92. PubMed ID: 16947017
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin antisense oligodeoxynucleotide-mediated stimulation of lymphocyte proliferation in culture.
Aguila MC; Rodriguez AM; Aguila-Mansilla HN; Lee WT
Endocrinology; 1996 May; 137(5):1585-90. PubMed ID: 8612489
[TBL] [Abstract][Full Text] [Related]
17. Microinfusion of a corticotrophin-releasing hormone receptor 1 antisense oligodeoxynucleotide into the dorsal hippocampus attenuates stress responses at specific times after stress exposure.
Kozlovsky N; Zohar J; Kaplan Z; Cohen H
J Neuroendocrinol; 2012 Mar; 24(3):489-503. PubMed ID: 22151651
[TBL] [Abstract][Full Text] [Related]
18. Elevated messenger RNA levels after antisense oligodeoxynucleotide treatment in vitro and in vivo.
Probst JC; Skutella T
Biochem Biophys Res Commun; 1996 Aug; 225(3):861-8. PubMed ID: 8780703
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing hormone is involved in conditioned stimulus-induced reduction of natural killer cell activity but not in conditioned alterations in cytokine production or proliferation responses.
Perez L; Lysle DT
J Neuroimmunol; 1995 Dec; 63(1):1-8. PubMed ID: 8557820
[TBL] [Abstract][Full Text] [Related]
20. Central leptin suppresses splenic lymphocyte functions through activation of the corticotropin-releasing hormone-sympathetic nervous system.
Okamoto S; Irie Y; Ishikawa I; Kimura K; Masayuki Saito
Brain Res; 2000 Feb; 855(1):192-7. PubMed ID: 10650150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
